STRATEGIC MARKETING INNOVATIONS

Lobbying for CARDINAL POINT PARTNERS, LLC ON BEHALF OF TONIX PHARMACEUTICALS · Federal relations firm

Filing Registration

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

District of Columbia

Lobbying activity 3

Defense

Funding for biodefense and pandemic preparedness medical countermeasures Patient access to novel non-opioid analgesics

Health Issues

Funding for biodefense and pandemic preparedness medical countermeasures Patient access to novel non-opioid analgesics

Disaster Planning/Emergencies

Funding for biodefense and pandemic preparedness medical countermeasures Patient access to novel non-opioid analgesics

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.